FDA 483 OBSERVATION · #1110 OF 1,932 MOST-CITED

Provide proper equipment to meet requirements

FDA cited this observation 14 times across 14 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Biologics14
BY FISCAL YEAR
FY20264
FY20252
FY20241
FY20221
FY20181
FY20172
FY20163

How FDA worded it — real examples

Failure of equipment to perform in the manner for which it was designed so as to assure compliance with the official requirements prescribed in 21 CFR 606.

BioLife Plasma Services L.P. · Thornton, Colorado · Biologics · 2026-06-25

Failure of equipment to perform in the manner for which it was designed so as to assure compliance with the official requirements prescribed in 21 CFR 606.

New York Blood Center Enterprises · New Hyde Park, New York · Biologics · 2026-02-19

Failure of equipment to perform in the manner for which it was designed so as to assure compliance with the official requirements prescribed in 21 CFR 606.

New York Blood Center Enterprises · Port Jefferson Station, New York · Biologics · 2026-02-11

Failure of equipment to perform in the manner for which it was designed so as to assure compliance with the official requirements prescribed in 21 CFR 606.

B Positive National Blood Services - Wilkes Barre, LLC · Edwardsville, Pennsylvania · Biologics · 2025-10-29

Failure of equipment to perform in the manner for which it was designed so as to assure compliance with the official requirements prescribed in 21 CFR 606.

Primary Children's Hospital - Miller Campus · Lehi, Utah · Biologics · 2025-04-24

Failure of equipment to perform in the manner for which it was designed so as to assure compliance with the official requirements prescribed in 21 CFR 606.

Biomat USA, Inc. · Cedar City, Utah · Biologics · 2025-01-09

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Biologics industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →